Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06504368 |
| Title | Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Next Oncology | RECRUITING | San Antonio | Texas | 78229 | United States | Details |